described an informative gene profiling of gliomagenesis, from which FBXW 7 emerges as a downregulated inhibitor of the MYC interacting pathway [ 34 ], reinforcing our findings that it is a highly significant predictor of aggressiveness.
← all excerpts
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
1
—
—